Meckel’s diverticulum is a rare congenital abnormality of the small intestine. It is believed to be caused by an incomplete closure of the vitelline duct, which is the embryonic precursor of the small intestine. The condition is often seen in infants and children, although it can be present in adults as well. Meckel’s diverticulum can be difficult to diagnose, as the symptoms can be similar to other gastrointestinal disorders. In this article, we will explore the history of Meckel’s diverticulum, its symptoms, diagnosis, and treatment.
Meckel’s diverticulum was first described by German physician Johann Friedrich Meckel in 1809. He noticed a small out-pouching of the small intestine in a cadaver and postulated that it was due to an incomplete closure of the vitelline duct. Since then, the condition has been named after him. Meckel’s diverticulum is the most common congenital abnormality of the small intestine. It is estimated to occur in 2-4% of the population, with a higher incidence in males. The condition is most commonly seen in infants and children, but can be present in adults as well.
Meckel’s diverticulum is often asymptomatic, meaning that it does not cause any symptoms. However, when symptoms do occur, they can range from mild to severe. The most common symptoms are abdominal pain, nausea, vomiting, and diarrhea. Other symptoms can include rectal bleeding, weight loss, and fever.
Meckel’s diverticulum can be difficult to diagnose, as the symptoms can be similar to other gastrointestinal disorders. The most common diagnostic test used to diagnose Meckel’s diverticulum is an abdominal ultrasound. This test can be used to detect the presence of a diverticulum in the small intestine. Other tests that may be used to diagnose Meckel’s diverticulum include a barium enema, a computed tomography (CT) scan, and an upper gastrointestinal (GI) series.
The treatment of Meckel’s diverticulum depends on the severity of the condition. In cases where the diverticulum is asymptomatic, no treatment may be necessary. However, if the diverticulum is causing symptoms, it may need to be surgically removed. This is known as a laparoscopic diverticulectomy.
Meckel’s diverticulum is a rare congenital abnormality of the small intestine. It is often asymptomatic, but can cause abdominal pain, nausea, vomiting, and diarrhea when symptoms do occur. Diagnosis is often done using an abdominal ultrasound, although other tests may be used as well. Treatment of Meckel’s diverticulum depends on the severity of the condition, but may involve surgical removal of the diverticulum. Despite its rarity, Meckel’s diverticulum is an important condition to be aware of. With early diagnosis and proper treatment, it can be managed effectively.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation